Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Short- and long-term corneal vascular effects of tafluprost eye drops.

Hos D, Koch KR, Bock F, Grajewski RS, Dietlein TS, Cursiefen C, Heindl LM.

Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):1919-27. doi: 10.1007/s00417-013-2345-0. Epub 2013 Apr 28.

PMID:
23624591
2.

Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.

Bucher F, Parthasarathy A, Bergua A, Onderka J, Regenfuss B, Cursiefen C, Bock F.

Acta Ophthalmol. 2014 Mar;92(2):143-8. doi: 10.1111/j.1755-3768.2012.02525.x. Epub 2012 Sep 20.

3.

Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.

Cursiefen C, Maruyama K, Jackson DG, Streilein JW, Kruse FE.

Cornea. 2006 May;25(4):443-7.

PMID:
16670483
4.

Differential distribution of blood and lymphatic vessels in the murine cornea.

Ecoiffier T, Yuen D, Chen L.

Invest Ophthalmol Vis Sci. 2010 May;51(5):2436-40. doi: 10.1167/iovs.09-4505. Epub 2009 Dec 17.

5.

b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern.

Hajrasouliha AR, Sadrai Z, Chauhan SK, Dana R.

Cornea. 2012 Jul;31(7):804-9. doi: 10.1097/ICO.0b013e31823f8b5a.

6.

Sunitinib inhibits inflammatory corneal lymphangiogenesis.

Detry B, Blacher S, Erpicum C, Paupert J, Maertens L, Maillard C, Munaut C, Sounni NE, Lambert V, Foidart JM, Rakic JM, Cataldo D, Noël A.

Invest Ophthalmol Vis Sci. 2013 May 3;54(5):3082-93. doi: 10.1167/iovs.12-10856.

PMID:
23580490
7.

Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.

Hos D, Saban DR, Bock F, Regenfuss B, Onderka J, Masli S, Cursiefen C.

Arch Ophthalmol. 2011 Apr;129(4):445-52. doi: 10.1001/archophthalmol.2011.42.

PMID:
21482870
8.

Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.

Hos D, Bachmann B, Bock F, Onderka J, Cursiefen C.

Exp Eye Res. 2008 Nov;87(5):427-32. doi: 10.1016/j.exer.2008.07.013. Epub 2008 Aug 8.

PMID:
18755186
9.

Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis.

Lipp M, Bucher F, Parthasarathy A, Hos D, Onderka J, Cursiefen C, Bock F.

Graefes Arch Clin Exp Ophthalmol. 2014 Jun;252(6):943-9. doi: 10.1007/s00417-014-2626-2. Epub 2014 Apr 15.

PMID:
24728466
10.

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.

Bock F, Onderka J, Dietrich T, Bachmann B, Kruse FE, Paschke M, Zahn G, Cursiefen C.

Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2545-52.

PMID:
17525183
11.

Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.

Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C.

Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):115-9. Epub 2007 Oct 2.

PMID:
17909835
12.

Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice.

Shi W, Ming C, Liu J, Wang T, Gao H.

Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):55-67. doi: 10.1007/s00417-010-1442-6. Epub 2010 Jul 17.

PMID:
20640436
13.

The effect of podoplanin inhibition on lymphangiogenesis under pathological conditions.

Maruyama Y, Maruyama K, Kato Y, Kajiya K, Moritoh S, Yamamoto K, Matsumoto Y, Sawane M, Kerjaschki D, Nakazawa T, Kinoshita S.

Invest Ophthalmol Vis Sci. 2014 Jul 1;55(8):4813-22. doi: 10.1167/iovs.13-13711.

PMID:
24985477
14.

The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages.

Maruyama K, Nakazawa T, Cursiefen C, Maruyama Y, Van Rooijen N, D'Amore PA, Kinoshita S.

Invest Ophthalmol Vis Sci. 2012 May 31;53(6):3145-53. doi: 10.1167/iovs.11-8010.

PMID:
22511631
15.

Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo.

Hos D, Koch KR, Bucher F, Bock F, Cursiefen C, Heindl LM.

Invest Ophthalmol Vis Sci. 2013 Sep 11;54(9):6133-42. doi: 10.1167/iovs.13-12460.

PMID:
23970469
16.

Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis.

Tang X, Sun J, Du L, Du H, Wang L, Mai J, Zhang F, Liu P.

Exp Eye Res. 2016 Feb;143:110-9. doi: 10.1016/j.exer.2015.10.017. Epub 2015 Oct 22.

PMID:
26500194
17.

Regression of mature lymphatic vessels in the cornea by photodynamic therapy.

Bucher F, Bi Y, Gehlsen U, Hos D, Cursiefen C, Bock F.

Br J Ophthalmol. 2014 Mar;98(3):391-5. doi: 10.1136/bjophthalmol-2013-303887. Epub 2014 Jan 10.

PMID:
24414403
18.

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.

Cursiefen C, Schlötzer-Schrehardt U, Küchle M, Sorokin L, Breiteneder-Geleff S, Alitalo K, Jackson D.

Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2127-35.

PMID:
12091407
19.

Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival.

Fukumoto A, Maruyama K, Walsh T, Kajiya K, Hamuro J, D'Amore PA, Kinoshita S.

Invest Ophthalmol Vis Sci. 2010 May;51(5):2450-8. doi: 10.1167/iovs.09-4618. Epub 2009 Dec 30.

PMID:
20042658
20.

Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?

Goyal S, Chauhan SK, El Annan J, Nallasamy N, Zhang Q, Dana R.

Arch Ophthalmol. 2010 Jul;128(7):819-24. doi: 10.1001/archophthalmol.2010.124.

Supplemental Content

Support Center